Cancer prevention involves resisting cancer development at its initial stages (NF-kB and p53), retarding angiogenesis (VEGF) and initiating cancer cell apoptosis (BAX/Bcl-2 and TNF-alpha). This evidence concerns the gene TP53 and cancer.